Carr Warner W
Allergy and Asthma Associates of Southern California, Viejo, California 92691, USA.
Allergy Asthma Proc. 2008 Jan-Feb;29(1):14-23. doi: 10.2500/aap2008.29.3074.
Allergic rhinitis (AR) is the most common cause of allergic disease in the pediatric population. This chronic condition impacts quality of life, exacerbates comorbid conditions, and results in a significant economic burden. With an accurate diagnosis, there are many available therapies to reduce the burden of AR. Options include allergen avoidance, pharmacotherapy, and immune modulation. This review provides a comprehensive discussion of the current and future state of the art in the treatment of pediatric AR.
过敏性鼻炎（AR）是儿科人群中最常见的过敏性疾病病因。这种慢性病会影响生活质量，加重合并症，并造成重大经济负担。通过准确诊断，有许多可用疗法来减轻AR的负担。这些选择包括避免接触过敏原、药物治疗和免疫调节。本综述全面讨论了儿科AR治疗的当前和未来的先进水平。
